Andreas Luchner
Overview
Explore the profile of Andreas Luchner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1770
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD
Seither B, Schober A, Allgaier R, Meindl C, Paulus M, Hubauer U, et al.
Indian Pacing Electrophysiol J
. 2024 Oct;
24(6):315-320.
PMID: 39461716
Aims: Plasma NT-proBNP is an established marker of heart failure. Previous studies suggested urinary NT-proBNP has potential as marker of chronic heart failure as well. The objective of this study...
2.
Wester M, Koll F, Luedde M, Langer C, Resch M, Luchner A, et al.
Clin Res Cardiol
. 2024 Oct;
113(12):1757-1767.
PMID: 39352518
Background: Decreases in symptom load and improvements in quality of life are important goals in the invasive treatment of symptomatic chronic coronary syndrome (CCS). To date, it is not known...
3.
Schach C, Reitschuster R, Benedikt D, Fussl E, Debl K, Maier L, et al.
Clin Cardiol
. 2023 Aug;
46(11):1337-1344.
PMID: 37573576
Background: Left atrial appendage closure (LAAC) is a mechanical alternative for stroke prevention in patients at risk who cannot tolerate oral anticoagulation (OAC). Hypothesis: Our hypothesis was that the reduction...
4.
Donhauser F, Zimmermann M, Steinkirchner A, Wiegrebe S, Dietl A, Brandl C, et al.
J Clin Med
. 2023 Mar;
12(6).
PMID: 36983106
Cardiovascular risk factors such as high glucose, LDL-cholesterol, blood pressure, and impaired kidney function are particularly frequent in old-aged individuals. However, population-based data on the extent of cardiovascular risk factor...
5.
Wester M, Koll F, Luedde M, Langer C, Resch M, Luchner A, et al.
Clin Res Cardiol
. 2022 Sep;
112(9):1194-1203.
PMID: 36100700
Background: Dyspnea is a frequent symptom in patients with stable coronary artery disease (CAD) and is recognized as a possible angina equivalent. Objectives: This study was to assess the impact...
6.
Paulus M, Renner K, Nickel A, Brochhausen C, Limm K, Zugner E, et al.
Basic Res Cardiol
. 2022 Sep;
117(1):45.
PMID: 36068416
Tachycardiomyopathy is characterised by reversible left ventricular dysfunction, provoked by rapid ventricular rate. While the knowledge of mitochondria advanced in most cardiomyopathies, mitochondrial functions await elucidation in tachycardiomyopathy. Pacemakers were...
7.
Allgaier R, Strack C, Wallner S, Hubauer U, Uecer E, Lehn P, et al.
Biomark Med
. 2022 Feb;
16(4):265-275.
PMID: 35176879
NAG and KIM-1 as markers of tubular damage are suggested as potential biomarkers for the cardiorenal syndrome. The aim of the study was to assess the prognostic capability of NAG...
8.
Wester M, Koll F, Ludde M, Langer C, Resch M, Luchner A, et al.
JACC Cardiovasc Interv
. 2021 Nov;
14(22):2525-2527.
PMID: 34794658
No abstract available.
9.
Bauer S, Strack C, Ucer E, Wallner S, Hubauer U, Luchner A, et al.
Biomark Med
. 2021 Nov;
15(18):1709-1719.
PMID: 34783584
We assessed the 10-year prognostic role of 11 biomarkers with different pathophysiological backgrounds. Blood samples from 144 patients with heart failure were analyzed. After 10 years of follow-up (median follow-up...
10.
Dietl A, Zimmermann M, Brandl C, Wallner S, Burkhardt R, Maier L, et al.
BMJ Open
. 2021 Nov;
11(11):e052004.
PMID: 34728452
Objective: European guidelines recommended a uniform upper reference limit of high-sensitivity cardiac troponin T (hsTnT) to rule out non-ST segment elevation myocardial infarction. Our study aimed to provide a hsTnT...